Skip to content

13F-HR filed by Euclidean Capital LLC

Euclidean Capital LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 10 holding rows worth $205,729,000.

Accession
0001012975-21-000458
Filed
2021-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 10 entries on the cover page, a total value of $205,729,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $205,729,000 with VALUE read as thousands by filing date, 13F file number 028-20777. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PMV PHARMACEUTICALS INC69353Y103COM2,769,813$82,540,000thousands by filing date
ALECTOR INC014442107COMMON STOCK980,894$22,384,000thousands by filing date
RAPT THERAPEUTICS INC75382E109COM635,177$19,722,000thousands by filing date
TENAYA THERAPEUTICS INC87990A106COM915,705$18,909,000thousands by filing date
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,261,261$17,569,000thousands by filing date
NGM BIOPHARMACEUTICALS INC62921N105COM832,274$17,494,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM777,193$16,251,000thousands by filing date
Surrozen, Inc.86889P109COM802,965$5,685,000thousands by filing date
1ST FINL BANCORP320209109COM173,576$4,063,000thousands by filing date
PDD HOLDINGS INC SPONSORED ADS722304102ADR12,262$1,112,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-21-000458this filing2021-11-15acceptance time not in the bulk data set